Acumen Pharmaceuticals, Inc. Payments to Acquire Productive Assets
Acumen Pharmaceuticals, Inc. (ABOS) reported Payments to Acquire Productive Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-08-12
- Acumen Pharmaceuticals, Inc. payments to acquire productive assets for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Acumen Pharmaceuticals, Inc. payments to acquire productive assets for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Acumen Pharmaceuticals, Inc. payments to acquire productive assets for the quarter ending 2025-12-31 was $0.00.
- Acumen Pharmaceuticals, Inc. payments to acquire productive assets for the quarter ending 2025-09-30 was $0.00.
- Acumen Pharmaceuticals, Inc. payments to acquire productive assets for fiscal 2025 was $88.00K, a 450.00% increase from fiscal 2024.
- Acumen Pharmaceuticals, Inc. payments to acquire productive assets for fiscal 2024 was $16.00K, a 23.81% decline from fiscal 2023.
- Acumen Pharmaceuticals, Inc. payments to acquire productive assets for fiscal 2023 was $21.00K, a 86.96% decline from fiscal 2022.
- Acumen Pharmaceuticals, Inc. payments to acquire productive assets for fiscal 2022 was $161.00K, a 302.50% increase from fiscal 2021.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | $9.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $9.00K derived: sum of 3 quarters · filed 2026-08-12 | $88.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $9.00K derived: sum of 2 quarters · filed 2026-08-12 | $88.00K 10-Q · filed 2025-11-12 | $88.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $88.00K 10-Q · filed 2026-08-12 | $88.00K derived: sum of 3 quarters · filed 2026-08-12 | $88.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $79.00K 10-Q · filed 2026-05-12 | $79.00K derived: sum of 2 quarters · filed 2026-05-12 | $79.00K derived: sum of 3 quarters · filed 2026-05-12 | $84.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $5.00K derived: sum of 3 quarters · filed 2026-03-26 | $16.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $5.00K derived: sum of 2 quarters · filed 2025-11-12 | $16.00K 10-Q · filed 2025-11-12 | $30.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $16.00K 10-Q · filed 2025-08-12 | $30.00K derived: sum of 3 quarters · filed 2025-08-12 | $37.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $11.00K 10-Q · filed 2025-05-13 | $25.00K derived: sum of 2 quarters · filed 2025-05-13 | $32.00K derived: sum of 3 quarters · filed 2025-05-13 | $32.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $21.00K derived: sum of 2 quarters · filed 2025-03-27 | $21.00K derived: sum of 3 quarters · filed 2025-03-27 | $21.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $7.00K derived: sum of 2 quarters · filed 2024-11-12 | $7.00K 10-Q · filed 2024-11-12 | $42.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $35.00K derived: sum of 3 quarters · filed 2024-08-13 | $116.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $35.00K derived: sum of 2 quarters · filed 2024-05-14 | $116.00K derived: sum of 3 quarters · filed 2024-05-14 | $152.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $116.00K derived: sum of 2 quarters · filed 2024-03-26 | $152.00K derived: sum of 3 quarters · filed 2024-03-26 | $161.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $117.00K derived: sum of 2 quarters · filed 2023-11-13 | $126.00K 10-Q · filed 2023-11-13 | $152.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $45.00K 10-Q · filed 2023-08-08 | $71.00K derived: sum of 3 quarters · filed 2023-08-08 | $79.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $9.00K 10-Q · filed 2023-05-09 | $35.00K derived: sum of 2 quarters · filed 2023-05-09 | $43.00K derived: sum of 3 quarters · filed 2023-05-09 | |
| 2021-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $34.00K derived: sum of 2 quarters · filed 2023-03-27 | $40.00K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $14.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $6.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |